None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men and women aged 19 ~ 75 2) LDL-cholesterol 140~189 mg/dL and total cholesterol ≥ 200 mg/dL
Exclusion criteria
Exclusion criteria: 1. a person who has taken lipid lowering agent study within 6 months before the screening test. 2. BMI < 18.5 kg/m^2 or, ≥ 35 kg/m^2 3. fasting glucose level ≥ 140 mg/dL 4. a person who is taking on diabetes medication or out of control hypertension(Systolic Blood Pressure ≥140 mmHg OR Diastolic Blood Pressure ≥100 mmHg) 5. Subjects who are sensitive to Saccaharum Officinalis L. wax alcohols(Policosanol) 6. have a Coagulation disorder or, taking anticoagulant, antithrombotic. 7. a person who has experience in antipsychotic medication within 3 months before the screening test. 8. history of alcoholism or substance abuse 9. Pregnant or lactating women 10. fertile women without proper contraceptives 11. Participation in other human study within 3 months before the screening test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL-cholesterol;Total cholesterol | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid metabolism index; Atherogenic index;Anthropometric index | — |
Countries
Korea, Republic of
Contacts
Wonkwang University, Gwangju Medical Center